Physician
Claudia Garcia
Claudia Garcia was paid $1.50M by Medicaid between Jan 2018 and Nov 2024, across 45 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 36% of everything it billed.
33Billing provider infoCLAUDIA GARCIA
HENDERSON, NV 89052
HENDERSON, NV 89052
33aNPI1205266129assigned 11/13/2013
33bProvider typePediatrics Physician
28Total paid$1.50M
24GClaims40,728
24DCodes billed45
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Pediatrics Physician providers in Nevada
Rank by total paid#40 of 267
Median peer was paid$116K
This provider vs. median13×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,968 | $140K | |
| 2019 | 8,034 | $267K | |
| 2020 | 5,808 | $229K | |
| 2021 | 6,432 | $265K | |
| 2022 | 5,674 | $224K | |
| 2023 | 5,100 | $192K | |
| 2024incomplete | 5,712 | $183K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 36% | 8,697 | 7,019 | $544K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 15% | 2,407 | 2,283 | $219K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 15% | 2,494 | 2,127 | $218K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 12% | 4,541 | 4,279 | $178K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.9% | 975 | 927 | $89K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 4.6% | 2,172 | 2,070 | $69K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.3% | 497 | 469 | $50K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.1% | 513 | 397 | $32K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.3% | 523 | 477 | $19K |
| 92567 | <1% | 1,278 | 1,131 | $14K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,224 | 1,146 | $12K |
| 94760 | <1% | 4,906 | 3,934 | $12K |
33 more codes
| 36416 | <1% | 1,485 | $6K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 68 | $6K |
| 99058 | <1% | 338 | $6K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 396 | $5K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 205 | $5K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 47 | $4K |
| 87807 | <1% | 469 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 217 | $3K |
| 85018 | <1% | 1,059 | $2K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 56 | $1K |
| J7633 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram | <1% | 54 | $948.60 |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 270 | $491.54 |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 271 | $354.10 |
| 94664 | <1% | 21 | $190.85 | |
| 81002 | <1% | 30 | $83.44 | |
| 96127 | <1% | 12 | $43.74 | |
| J7610 | Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg | <1% | 30 | $31.98 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 99 | $26.02 |
| 99000 | <1% | 1,386 | $0.37 | |
| 90671 | 0% | 240 | $0.00 | |
| 90670 | 0% | 903 | $0.00 | |
| 90633 | 0% | 220 | $0.00 | |
| 90700 | 0% | 200 | $0.00 | |
| 90648 | 0% | 18 | $0.00 | |
| 90713 | 0% | 15 | $0.00 | |
| 90685 | 0% | 21 | $0.00 | |
| 90734 | 0% | 12 | $0.00 | |
| 90686 | 0% | 1,018 | $0.00 | |
| 90680 | 0% | 477 | $0.00 | |
| 90698 | 0% | 550 | $0.00 | |
| 90651 | 0% | 43 | $0.00 | |
| 90744 | 0% | 233 | $0.00 | |
| 97802 | 0% | 38 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGARCIA, CLAUDIA (OWNER)